Leng, Kun
Kampmann, Martin http://orcid.org/0000-0002-3819-7019
Funding for this research was provided by:
National Institute on Aging (R01 AG062359, U01 AG072464, F30 AG066418)
National Institute of Neurological Disorders and Stroke (U54 NS123746)
Tau Consortium
Chan Zuckerberg Initiative (Ben Barres Early Career Acceleration Award)
Article History
Received: 4 May 2022
Accepted: 2 November 2022
First Online: 18 November 2022
Declarations
:
: Not applicable.
: Not applicable.
: Martin Kampmann is an inventor on US patent 11,254,933 related to CRISPRi and CRISPRa screening, serves on the scientific advisory boards of Engine Biosciences, Casma Therapeutics, and Cajal Neuroscience and Alector, and is a consultant to Modulo Bio. The remaining author declares no competing interests.